2,856 Shares in Humana Inc. $HUM Purchased by United Services Automobile Association

United Services Automobile Association bought a new stake in Humana Inc. (NYSE:HUM) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 2,856 shares of the insurance provider’s stock, valued at approximately $756,000.

Other hedge funds also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares during the last quarter. Riverview Trust Co acquired a new position in shares of Humana during the 1st quarter worth about $34,000. Garde Capital Inc. bought a new position in shares of Humana in the 1st quarter valued at about $36,000. Zions Bancorporation National Association UT acquired a new stake in shares of Humana in the first quarter valued at about $37,000. Finally, Whipplewood Advisors LLC raised its holdings in Humana by 639.1% during the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider’s stock worth $45,000 after acquiring an additional 147 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Royal Bank Of Canada boosted their price target on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research report on Thursday, August 21st. Piper Sandler lowered their price objective on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research note on Thursday, July 31st. Barclays raised their target price on shares of Humana from $275.00 to $315.00 and gave the company an “equal weight” rating in a research note on Friday. Morgan Stanley dropped their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Finally, Sanford C. Bernstein lifted their target price on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research note on Friday. Seven analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $289.24.

Humana Stock Performance

HUM opened at $310.39 on Tuesday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The business has a fifty day simple moving average of $262.79 and a 200 day simple moving average of $256.68. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $357.00. The company has a market capitalization of $37.33 billion, a PE ratio of 23.82, a price-to-earnings-growth ratio of 1.81 and a beta of 0.44.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same period in the prior year, the business posted $6.96 EPS. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Friday, September 26th. Humana’s payout ratio is presently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.